Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Stephanie Lowenhaupt"'
Autor:
Stephanie Lowenhaupt, Angela Molloy
Publikováno v:
Contemporary Clinical Trials Communications, Vol 23, Iss , Pp 100821- (2021)
The COVID-19 pandemic abruptly forced changes in how to conduct multicenter clinical research. Gone were the days of face-to-face meetings and working together in person. Virtual teams became the norm rather than exception. The Network for Excellence
Externí odkaz:
https://doaj.org/article/aa9c617f71874060b169eb10e21a0033
Autor:
Michael J. Brownstein, Neal G. Simon, Jeffrey D. Long, Jon Yankey, Hilda T. Maibach, Merit Cudkowicz, Christopher Coffey, Robin A. Conwit, Codrin Lungu, Karen E. Anderson, Steven M. Hersch, Dixie J. Ecklund, Eve M. Damiano, Debra E. Itzkowitz, Shifang Lu, Marianne K. Chase, Jeremy M. Shefner, Andrew McGarry, Brenda Thornell, Catherine Gladden, Michele Costigan, Padraig O'Suilleabhain, Frederick J. Marshall, Amy M. Chesire, Paul Deritis, Jamie L. Adams, Peter Hedera, Kelly Lowen, H. Diana Rosas, Amie L. Hiller, Joseph Quinn, Kellie Keith, Andrew P. Duker, Christina Gruenwald, Angela Molloy, Cara Jacob, Stewart Factor, Elaine Sperin, Danny Bega, Zsazsa R. Brown, Lauren C. Seeberger, Victor W. Sung, Melanie Benge, Sandra K. Kostyk, Allison M. Daley, Susan Perlman, Valerie Suski, Patricia Conlon, Matthew J. Barrett, Stephanie Lowenhaupt, Mark Quigg, Joel S. Perlmutter, Brenton A. Wright, Elaine Most, Guy J. Schwartz, Jessica Lamb, Rosalind S. Chuang, Carlos Singer, Karen Marder, Joyce A. Moran, John R. Singleton, Meghan Zorn, Paola V. Wall, Richard M. Dubinsky, Carolyn Gray, Carolyn Drazinic
Publikováno v:
Journal of Clinical Medicine, Vol 9, Iss 11, p 3682 (2020)
SRX246 is a vasopressin (AVP) 1a receptor antagonist that crosses the blood-brain barrier. It reduced impulsive aggression, fear, depression and anxiety in animal models, blocked the actions of intranasal AVP on aggression/fear circuits in an experim
Externí odkaz:
https://doaj.org/article/54fcf4915f3243bdbb6939496de0752c
Autor:
Valentina Baljak, Stephanie Lowenhaupt, Matthew T. Clark, Jaideep Kapur, Juliana Leonardo, Mark Quigg, Andrew C. Schomer, Morgan Lynch
Publikováno v:
Epilepsia
Our objective was to determine the effect of sleep on heart rate following a recorded seizure. We prospectively acquired heart rate data in hospitalized epilepsy monitoring unit patients. We analyzed heart rate trends for multiple seizures (n = 101)
Autor:
Melanie Benge, Amie L. Hiller, Carolyn Gray, Michele Costigan, H. Diana Rosas, Stephanie Lowenhaupt, Rosalind S Chuang, Peter Hedera, Danny Bega, Matthew J. Barrett, Marianne Chase, Jon W. Yankey, Jessica Lamb, Elaine Sperin, Susan Perlman, Christina Gruenwald, Joseph F. Quinn, Joyce Ann Moran, Lauren Seeberger, Debra E Itzkowitz, Brenton A Wright, Kelly Lowen, Karen E. Anderson, Victor W. Sung, Angela Molloy, Frederick J. Marshall, Patricia Conlon, Hilda T Maibach, Jamie L Adams, Elaine Most, Stewart A. Factor, Karen Marder, Allison M. Daley, Shifang Lu, Carlos Singer, Michael J Brownstein, Neal G. Simon, Amy M Chesire, Valerie Suski, Codrin Lungu, Kellie Keith, Christopher S. Coffey, Guy J Schwartz, Zsazsa R Brown, Richard Dubinsky, Catherine Gladden, Paola Wall, Jeremy M. Shefner, Steven M. Hersch, Cara Jacob, Jeffrey D. Long, Dixie Ecklund, Padraig E. O'Suilleabhain, Andrew P. Duker, J. Singleton, Meghan Zorn, Carolyn Drazinic, Mark Quigg, Eve M Damiano, Sandra K. Kostyk, Brenda Thornell, Andrew McGarry, Merit Cudkowicz, Robin Conwit, Paul Deritis, Joel S. Perlmutter
Publikováno v:
Journal of Clinical Medicine
Volume 9
Issue 11
Journal of Clinical Medicine, Vol 9, Iss 3682, p 3682 (2020)
Volume 9
Issue 11
Journal of Clinical Medicine, Vol 9, Iss 3682, p 3682 (2020)
SRX246 is a vasopressin (AVP) 1a receptor antagonist that crosses the blood-brain barrier. It reduced impulsive aggression, fear, depression and anxiety in animal models, blocked the actions of intranasal AVP on aggression/fear circuits in an experim
Autor:
Angela Molloy, Stephanie Lowenhaupt
Publikováno v:
Contemporary Clinical Trials Communications
Contemporary Clinical Trials Communications, Vol 23, Iss, Pp 100821-(2021)
Contemporary Clinical Trials Communications, Vol 23, Iss, Pp 100821-(2021)
The COVID-19 pandemic abruptly forced changes in how to conduct multicenter clinical research. Gone were the days of face-to-face meetings and working together in person. Virtual teams became the norm rather than exception. The Network for Excellence
Autor:
Jean Baptiste Le Pichon, Stephanie Lowenhaupt, Jessica Lamb, Eric D. Foster, Patricia K. Coyle, Mariam Andersen, Christine Annis, Alexander J. Stein, Angela Molloy, Tracy A. Glauser, Laurie Gutmann, Steven M. Greenberg, Mengesha Teshome, A. Gordon Smith, Richard J. Barohn, Paula R. Clemens, Susan T. Iannaccone, Robert G. Holloway, Carole Seeley, Luis J. Mejico, Audrey Ellis, Bjorn Oskarsson, Jeremy M. Shefner, Emine O. Bayman, R. Peters, Anthony A. Amato, Louis B. Nabors, Beth A. Malow, Blagovest Nikolov, Mark Quigg, Claudia A. Chiriboga, Peggy Clark, Christine L. Amity, Mark P. Goldberg, Joseph F. Quinn, Trevis Huff, E. Clarke Haley, Codrin Lungu, Kellie Keith, David B. Clifford, Julie Steele, Stephen J. Kolb, Michael Benatar, Muhammad Maaz Iqbal, Shlomo Shinnar, Lawrence R. Wechsler, Basil T. Darras, Melanie Benge, Robin Conwit, Tanya Simuni, Catherine P. Canamar, Timothy Vollmer, Roger J. Packer, Michael Bosch, Khurram Bashir, Sara DeGregorio, Karen W. Adkins, James Bowen, Tina Ward, Dixie Ecklund, Marianne Chase, Bruce H. Dobkin, Stewart A. Factor, Gil I. Wolfe, Katy Mahoney, James C. Torner, Donna Patch, Mariana Doudova, Amy Bartlett, Nadege Gilles, Jeffrey D. Long, Caryl Tongco, Karen Marder, Claire Henchcliffe, Joyce Ann Moran, Mazen M. Dimachkie, Jon W. Yankey, Merit Cudkowicz, J. Robinson Singleton, Craig M. McDonald, Christopher S. Coffey, Annemarie Crumlish, Noreen L. Connolly, Brenda Thornell, John T. Kissel, Steven R. Levine, Kevin J. Staley, Erik K Henricson, Daniel Woo
Publikováno v:
JAMA Neurol
Importance One major advantage of developing large, federally funded networks for clinical research in neurology is the ability to have a trial-ready network that can efficiently conduct scientifically rigorous projects to improve the health of peopl
Autor:
Stephanie Lowenhaupt, Debra Babcock, Bernard Ravina, Liana Baker, Pei Shieen Wong, Sheng Luo, Pauline LeBlanc, Barbara C. Tilley, Julie H. Carter, Robert A. Hauser, Nabila Dahodwala, Marina E. Emborg, David Simon, Rohit Dhall, John Y. Fang, Andrew Feigin, Richard M. Zweig, Jacci Bainbridge, John C. Morgan, Binit B. Shah, Karen Williams, Kathleen M. Shannon, Buff Farrow, Karl Kieburtz, Daniel D. Truong, Renee Wagner, Cindy Zadikoff, Tanya Simuni, Sofya Glazman, Carlos Singer, Mark F. Lew, Kelvin L. Chou, Rajesh Pahwa, Saloni Sharma, Cornelia Kamp, James T. Boyd, Jordan J. Elm, Maureen A. Leehey, John L. Goudreau, Burton L. Scott, Adriana Pérez, Franca Cambi, Ivan Bodis-Wollner, Anne-Marie Wills, Stephen L. Lee, Jay S. Schneider, G. Webster Ross, Richard B. Dewey
Publikováno v:
The Lancet Neurology. 14:795-803
Summary Background A systematic assessment of potential disease-modifying compounds for Parkinson's disease concluded that pioglitazone could hold promise for the treatment of patients with this disease. We assessed the effect of pioglitazone on the
Autor:
Richard D. Stevenson, Maxine M. Kuroda, Deborah Gaebler-Spira, Hongying Dai, Andrea Gaedigk, Yang He, Ann Tilton, Jilda Vargus-Adams, Alexander H. Hoon, Andrew Lewandowski, Linda E. Krach, Christina Lopez, John F. McLaughlin, Ana Christensen, Diane Kennedy, Stephanie Lowenhaupt, J. Steven Leeder, Liu Lin Thio, Shellie Lackey, Maureen Butler, Nienke P. Dosa, Janice E. Brunstrom-Hernandez, Elaine E. Stashinko, Aloysia Schwabe, William J. Jusko, Desiree Roge
Publikováno v:
The Journal of pediatrics. 164(5)
Objective To characterize the population pharmacokinetics (PK) of oral baclofen and assess impact of patient-specific covariates in children with cerebral palsy (CP) in order to support its clinical use. Subjects design Children (2-17 years of age) w